Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026
Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025 Cash of $17.6 Million at December 31, 2025 LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ: ISPR) ("Ispire," the "Company,"...
Docquity and Novartis Partner to Tackle Retinal Health Challenges in Malaysia
The multi-year collaboration leverages Docquity's Awareness to Advocacy (A2A) Program to expand retinal health education amongst thousands of HCPs and widen access to retinal health products With 81.5% of Southeast Asian doctors participating in...